NMRA
Neumora Therapeutics, Inc.
Phase 3
Estimated
NMRA-335140
Major Depressive Disorder
T-minus 313 days
~ Jun 30, 2027
ClinicalTrials.gov
verified 2mo ago
Countdown card →